Your browser doesn't support javascript.
loading
Intensity of Cyclophosphamide-Based Bridging Therapy Before Chimeric Antigen Receptor T Cell Therapy in Myeloma.
Zafar, Aneeqa; Huang, Chiung-Yu; Lo, Mimi; Arora, Shagun; Chung, Alfred; Wong, Sandy W; Wolf, Jeffrey; Martin, Thomas G; Shah, Nina; Banerjee, Rahul.
Afiliação
  • Zafar A; Department of Medicine, University of California San Francisco, San Francisco, California.
  • Huang CY; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.
  • Lo M; Division of Hematology and Oncology, Department of Pharmacy, University of California San Francisco, San Francisco, California.
  • Arora S; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Chung A; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Wong SW; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Wolf J; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Martin TG; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Shah N; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Banerjee R; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington. Electronic address: rahul.banerjee.md@gmail.com.
Transplant Cell Ther ; 29(8): 504.e1-504.e7, 2023 08.
Article em En | MEDLINE | ID: mdl-37244643
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / Mieloma Múltiplo Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2023 Tipo de documento: Article